BHG Lii, LLC

BHG Lii, LLC, doing business as BHG Jackson Treatment Center, operates exclusively as a federal grant sub-recipient delivering medication-assisted treatment (MAT) services to state behavioral health systems. The Jackson, Georgia-based limited liability partnership holds no federal contracts or prime awards; all three recent federal awards are sub-grants flowing from the Department of Health and Human Services Substance Abuse and Mental Health Services Administration through the Georgia Department of Behavioral Health and Developmental Disabilities.

The vendor's federal footprint is concentrated and nascent. Since November 2023, BHG Jackson has received three sub-grant awards totaling $1.2 million in combined obligations, all designated for medication-assisted treatment. The award velocity shows two awards in 2024 following one in late 2023. The single customer agency across all awards is HHS SAMHSA operating through Georgia's state behavioral health authority as the prime grantee. Because all activity flows through state grantees rather than direct federal awards, the vendor operates in the sub-recipient tier of federal grant distribution and does not maintain seats on federal contract vehicles or compete under federal procurement set-asides.

The work footprint reflects a healthcare service delivery model rather than a federal contracting posture. BHG Jackson's federal activity is limited to substance abuse treatment programming delivered through state block-grant mechanisms; there is no indication of broader federal service lines, multiagency exposure, or prime contracting capability. The concentration of all three awards within a single federal grant program and a single state grantee represents both the vendor's current niche and a significant dependency on continued state-level MAT funding allocation.